6586.TWO
Price:
$30.95
Market Cap:
$6.62B
CHO Pharma, Inc., engages in research and development of biotechnology in Taiwan. It develops glycoengineering platform technologies, including SAR-based glycoengineered biobetters; glycosite-specific antibody-drug conjugates (ADCs); novel antibodies and vaccines targeting novel carbohydrate antigens; and programs using its glycoengineering technologies. The company also provides CHOptimax, an in vitro enzymatic one-pot process that converts naked antibodies into glycoengineered biobetter or ADC. In addition, the company develops CHO-H01, which is in Phase I/IIa clinical trials for the treatment of refractory non-Hodgkin lymphoma; CHO-A04, a humanized monoclonal antibody, which is in phase I...[Read more]
Industry
Biotechnology
IPO Date
2017-09-28
Stock Exchange
TWO
Ticker
6586.TWO
According to CHO Pharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.48B. This represents a change of -45.12% compared to the average of 11.80B of the last 4 quarters.
The mean historical Enterprise Value of CHO Pharma, Inc. over the last ten years is 11.62B. The current 6.48B Enterprise Value has changed 5.47% with respect to the historical average. Over the past ten years (40 quarters), 6586.TWO's Enterprise Value was at its highest in in the December 2022 quarter at 24.18B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.
Average
11.62B
Median
12.04B
Minimum
3.18B
Maximum
24.25B
Discovering the peaks and valleys of CHO Pharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 303.81%
Maximum Annual Enterprise Value = 24.25B
Minimum Annual Increase = -46.16%
Minimum Annual Enterprise Value = 3.18B
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 11.03B | -15.52% |
| 2023 | 13.05B | -46.16% |
| 2022 | 24.25B | 66.07% |
| 2021 | 14.60B | 303.81% |
| 2020 | 3.62B | 13.88% |
The current Enterprise Value of CHO Pharma, Inc. (6586.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
16.11B
5-year avg
13.31B
10-year avg
11.62B
CHO Pharma, Inc.’s Enterprise Value is less than Mycenax Biotech Inc. (7.51B), less than Adimmune Corporation (9.19B), less than TaiGen Biopharmaceuticals Holdings Limited (8.27B), greater than Pharmosa Biopharm Inc. (6.25B), less than OBI Pharma, Inc. (6.99B), less than AP Biosciences Inc (10.96B), greater than Acepodia, Inc. (3.94B), less than Sinphar Pharmaceutical Co.,Ltd. (6.61B), greater than BioGend Therapeutics Co., Ltd. (4.66B), less than Formosa Laboratories, Inc. (9.83B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 7.51B | $6.74B | |
| 9.19B | $8.20B | |
| 8.27B | $8.22B | |
| 6.25B | $6.84B | |
| 6.99B | $7.59B | |
| 10.96B | $12.26B | |
| 3.94B | $8.78B | |
| 6.61B | $5.83B | |
| 4.66B | $4.88B | |
| 9.83B | $7.53B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CHO Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CHO Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is CHO Pharma, Inc.'s Enterprise Value?
What is the highest Enterprise Value for CHO Pharma, Inc. (6586.TWO)?
What is the 3-year average Enterprise Value for CHO Pharma, Inc. (6586.TWO)?
What is the 5-year average Enterprise Value for CHO Pharma, Inc. (6586.TWO)?
How does the current Enterprise Value for CHO Pharma, Inc. (6586.TWO) compare to its historical average?